Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Rockwell Medical's gross margin for the twelve months ending Jun 30, 2026 was 17.7%. For fiscal 2025 it was 16.9%, against 17.2% the year before. The highest annual figure on record is 17.2% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16.9% | −0.3 |
| FY2024 | Dec 31, 2024 | 17.2% | +6.8 |
| FY2023 | Dec 31, 2023 | 10.4% | +4.8 |
| FY2022 | Dec 31, 2022 | 5.6% | +9.5 |
| FY2021 | Dec 31, 2021 | -3.9% | −8.3 |
| FY2020 | Dec 31, 2020 | 4.4% | −0.2 |
| FY2019 | Dec 31, 2019 | 4.6% | +7.1 |
| FY2018 | Dec 31, 2018 | -2.5% | −9.0 |
| FY2017 | Dec 31, 2017 | 6.5% | −6.2 |
| FY2016 | Dec 31, 2016 | 12.7% | −3.5 |
| FY2015 | Dec 31, 2015 | 16.1% | +0.4 |
| FY2014 | Dec 31, 2014 | 15.8% | +3.1 |
| FY2013 | Dec 31, 2013 | 12.7% | −0.7 |
| FY2012 | Dec 31, 2012 | 13.4% | +1.9 |
| FY2011 | Dec 31, 2011 | 11.5% | −5.0 |
| FY2010 | Dec 31, 2010 | 16.6% | +2.1 |
| FY2009 | Dec 31, 2009 | 14.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 18.2% | +2.7 |
| Q1 FY2026 | Mar 31, 2026 | 16.7% | +0.6 |
| Q4 FY2025 | Dec 31, 2025 | 21.1% | +6.4 |
| Q3 FY2025 | Sep 30, 2025 | 14.3% | −7.8 |
| Q2 FY2025 | Jun 30, 2025 | 15.6% | −2.0 |
| Q1 FY2025 | Mar 31, 2025 | 16.1% | +2.6 |
| Q4 FY2024 | Dec 31, 2024 | 14.7% | +1.7 |
| Q3 FY2024 | Sep 30, 2024 | 22.0% | +12.8 |
| Q2 FY2024 | Jun 30, 2024 | 17.6% | +11.9 |
| Q1 FY2024 | Mar 31, 2024 | 13.5% | +0.3 |
| Q4 FY2023 | Dec 31, 2023 | 13.0% | +0.9 |
| Q3 FY2023 | Sep 30, 2023 | 9.3% | +5.1 |
| Q2 FY2023 | Jun 30, 2023 | 5.7% | −3.6 |
| Q1 FY2023 | Mar 31, 2023 | 13.2% | +18.1 |
| Q4 FY2022 | Dec 31, 2022 | 12.1% | +26.7 |
| Q3 FY2022 | Sep 30, 2022 | 4.2% | +6.2 |
| Q2 FY2022 | Jun 30, 2022 | 9.3% | +11.1 |
| Q1 FY2022 | Mar 31, 2022 | -4.9% | −7.5 |
| Q4 FY2021 | Dec 31, 2021 | -14.6% | −17.1 |
| Q3 FY2021 | Sep 30, 2021 | -2.1% | −4.3 |
| Q2 FY2021 | Jun 30, 2021 | -1.7% | −7.3 |
| Q1 FY2021 | Mar 31, 2021 | 2.6% | −4.4 |
| Q4 FY2020 | Dec 31, 2020 | 2.5% | −4.6 |
| Q3 FY2020 | Sep 30, 2020 | 2.3% | +2.4 |
| Q2 FY2020 | Jun 30, 2020 | 5.5% | +0.6 |
| Q1 FY2020 | Mar 31, 2020 | 7.0% | +0.5 |
| Q4 FY2019 | Dec 31, 2019 | 7.2% | +0.2 |
| Q3 FY2019 | Sep 30, 2019 | -0.1% | −11.9 |
| Q2 FY2019 | Jun 30, 2019 | 4.9% | +31.9 |
| Q1 FY2019 | Mar 31, 2019 | 6.5% | +11.3 |
| Q4 FY2018 | Dec 31, 2018 | 7.0% | +15.3 |
| Q3 FY2018 | Sep 30, 2018 | 11.8% | +4.5 |
| Q2 FY2018 | Jun 30, 2018 | -26.9% | −38.2 |
| Q1 FY2018 | Mar 31, 2018 | -4.8% | −21.0 |
| Q4 FY2017 | Dec 31, 2017 | -8.3% | −23.1 |
| Q3 FY2017 | Sep 30, 2017 | 7.3% | −5.0 |
| Q2 FY2017 | Jun 30, 2017 | 11.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 16.2% | – |
| Q4 FY2016 | Dec 31, 2016 | 14.8% | – |
| Q3 FY2016 | Sep 30, 2016 | 12.3% | – |
See a number that looks wrong?